Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

RATIONALE: Symptom relief is a key treatment goal in patients with chronic obstructive pulmonary disease (COPD). However, there are limited data available on the response to bronchodilator therapy in patients at low risk of exacerbations with different levels of symptom severity. This study compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, Maltais, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659027/
https://www.ncbi.nlm.nih.gov/pubmed/33167780
http://dx.doi.org/10.1177/1753466620968500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659027/
https://www.ncbi.nlm.nih.gov/pubmed/33167780
http://dx.doi.org/10.1177/1753466620968500

Ejemplares similares